Activated platelets in multiple sclerosis: Immunoinflammatory mechanisms and the therapeutic controversy of acetylsalicylic acid.

Al-Jehani H, Al-Kuraishy HM, Elkady WA, Musa A, Batiha GE.

Open source

DOI
10.1016/j.msard.2026.107917
Published
2026-09-08
Container
Mult Scler Relat Disord
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2026.107917,
  title = {Activated platelets in multiple sclerosis: Immunoinflammatory mechanisms and the therapeutic controversy of acetylsalicylic acid.},
  author = {Al-Jehani H and  Al-Kuraishy HM and  Elkady WA and  Musa A and  Batiha GE.},
  year = {2026},
  journal = {Mult Scler Relat Disord},
  doi = {10.1016/j.msard.2026.107917},
  url = {https://doi.org/10.1016/j.msard.2026.107917}
}

RIS

TY  - JOUR
TI  - Activated platelets in multiple sclerosis: Immunoinflammatory mechanisms and the therapeutic controversy of acetylsalicylic acid.
AU  - Al-Jehani H
AU  -  Al-Kuraishy HM
AU  -  Elkady WA
AU  -  Musa A
AU  -  Batiha GE.
PY  - 2026
JO  - Mult Scler Relat Disord
DO  - 10.1016/j.msard.2026.107917
UR  - https://doi.org/10.1016/j.msard.2026.107917
ER  - 

APA

H, A., HM, A., WA, E., A, M., & GE., B. (2026). Activated platelets in multiple sclerosis: Immunoinflammatory mechanisms and the therapeutic controversy of acetylsalicylic acid.. Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2026.107917

Source records